JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2009, 58(1):14-20

A study of the properties of compacts from directly compressible fructose

J. Mužíková*, S. Lišková
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Technology

The paper deals with a study of tensile strength and disintegration time of compacts from directly compressible fructose Advantose FS 95 and its mixture with microcrystalline cellulose Vivapur 102 in the ratio of 1:1 in dependence on compression force. It examines the effect of an addition of two lubricants, magnesium stearate and sodium stearyl fumarate, in the concentration of 1%, and an addition of active ingredients, ascorbic acid and acetylsalicylic acid in the concentration of 50%. In the case of Advantose FS 95, no statistically significant difference was observed in the values of strength of compacts within the type of the lubricant employed with an exception of the compression force of 10 kN, where the strength of tablets was lower with sodium stearyl fumarate. Compacts from the mixture of Advantose FS 95 with Vivapur 102 had a higher strength. Its values were markedly decreased by the action of lubricants, more in the case of magnesium stearate. Disintegration time of tablets in the case of Advantose FS 95 was prolonged more by magnesium stearate and in the case of the mixture of dry binders, sodium stearyl fumarate. Tablets with acetylsalicylic acid had a significantly higher strength and also a longer disintegration time than those with ascorbic acid.

Keywords: Advantose FS 95; Vivapur 102; lubricants; tensile strength of tablets; disintegration time of tablets
Grants and funding:

The study was supported by the grant MSM 0021620822 and by the firm SPI Pharma group and J. Rettenmaier & Söhne GmbH + Co, which supplied the samples of the dry binders tested.

Received: November 5, 2008; Accepted: December 20, 2008; Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mužíková J, Lišková S. A study of the properties of compacts from directly compressible fructose. Čes. slov. farm. 2009;58(1):14-20.
Download citation

References

  1. Bolhuis, G.K., Armstrong, N. A.: Pharm. Dev. Technol., 2006; 11, 111-124. Go to original source... Go to PubMed...
  2. Van der Voort Maarschalk, K., Bolhuis, G.K.: Pharm. Technol., 1999; 23, 34-42.
  3. Van der Voort Maarschalk, K., Vromans, H., Bolhuis, G.K., Lerk, C. F.: Eur. J. Pharm. Biopharm., 1996; 42, 49-55.
  4. Kibbe, A. H.: Handbook of pharmaceutical excipients. 3rd Ed. London: APhA Washington and PhP 2000; 210-212.
  5. Osberger, T. F.: Pharmaceut. Technol., 1979; 3, 81-86.
  6. SPI Pharma: Advantose ™FS 95 Fructose, Firm. lit. - http://www.spipharma.com/ProductsFolder/103Advantose/103/Advantose95.html (2007).
  7. Fell, J. T., Newton, J. M.: J. Pharm. Sci., 1970; 59, 688-691. Go to original source... Go to PubMed...
  8. Bos, C. E., H. Bolhuis, H., Van Doorne, Lerk, C. F.: Pharm. Weekbl., 1987; Sci. Ed. 9, 274-282. Go to original source... Go to PubMed...
  9. Belousov, V. A.: Khim. Farm. Zh., 1976; 10, 105-111. Go to original source...
  10. Jarosz, P. J., Parrott, E. L.: Drug Dev. Ind. Pharm., 1984; 10, 259-273. Go to original source...
  11. Bolhuis, G. K., Z. T. Chowhan, Z. T.: Materials for direct compaction. In: Alderborn, G, Nystrőm, Ch. (eds.) Pharmaceutical Powder Compaction Technology, Inc.: New York: Marcel Dekker 1996; 419-500. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.